BeOne Medicines (ONC) Exchange Rate Effect (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Exchange Rate Effect data on file, last reported at $19.3 million in Q1 2026.

• On a quarterly basis, Exchange Rate Effect rose 455.17% year-over-year to $19.3 million in Q1 2026; TTM through Mar 2026 was $75.9 million, a 394.19% increase from a year earlier, with the FY2025 full-year figure at $60.0 million, up 216.09% from the prior year.
• Exchange Rate Effect for Q1 2026 stood at $19.3 million, down from $23.2 million in the prior quarter.
• Over the last five years, Exchange Rate Effect for ONC reached as high as $64.5 million in Q4 2022 and fell as low as -$80.2 million in Q2 2022.
• Historically, Exchange Rate Effect has averaged -$2.9 million across 5 years, with a median of $9.0 million in 2022.
• Across the five-year window, Exchange Rate Effect slumped 4247.95% in 2022 and surged 5299.62% in 2024, its largest moves.
• Year by year, Exchange Rate Effect stood at $64.5 million in 2022, then slumped by 34.52% to $42.3 million in 2023, then plunged by 222.35% to -$51.7 million in 2024, then surged by 144.79% to $23.2 million in 2025, then retreated by 16.59% to $19.3 million in 2026.
• Per Business Quant data, the three most recent Exchange Rate Effect figures were $19.3 million in Q1 2026, $23.2 million in Q4 2025, and $9.9 million in Q3 2025.